Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · OptimizeRx Corp (OPRX)

OptimizeRx Q2 revenue falls 30% to $20.5 million, swings to $0.7 million net loss

Negative Impact 4 of 5 earnings Written later

OptimizeRx reported second-quarter 2026 revenue of $20.5 million, down 30% from $29.2 million a year earlier, and a GAAP net loss of $0.7 million, compared with net income of $1.5 million in the prior-year quarter. The company reaffirmed its fiscal 2026 guidance of $95 million to $100 million in revenue and $21 million to $25 million in adjusted EBITDA, and said it will also transition its finance leadership, with Andy D'Silva becoming CFO and Heather Favazza Chief Accounting Officer on January 1, 2027.

Key points

  • Q2 2026 revenue was $20.5 million, down from $29.2 million in Q2 2025; adjusted EBITDA was $4.9 million, down from $5.8 million
  • GAAP net loss was $(0.7) million, or $(0.04) per share, versus net income of $1.5 million, or $0.08 per share, a year earlier
  • Fiscal 2026 guidance reiterated: revenue of $95 million to $100 million and adjusted EBITDA of $21 million to $25 million
  • Edward Stelmakh steps down as Chief Financial & Strategy Officer effective December 31, 2026, and will serve as an advisor through December 31, 2027

The filing

CompanyOptimizeRx Corp (OPRX)
Form8-K, current report
Filed with the SECAug 12, 2026, 4:07 PM ET
Accession number0001448431-26-000014

Items reported: 2.02 Results of Operations5.02 Director / Officer Change7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 10:08 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 12, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.